Bluemtec KRX:439580KOSDAQ

블루엠텍 · Korean news coverage and regulatory filings, organized.

Articles, 24h0
Articles, 7 days3
DART filings, 7 days1
Articles tracked5since Sep 11

In Q2 2026, Bluemtec reported revenue of ₩55.0bn, up 20.4% year on year, and operating profit of ₩182m. Bluemtec (블루엠텍) appeared in 3 Korean news articles and 1 DART filing over the past seven days. Coverage peaked on Sep 30 with 2 articles. The most common catalyst was stakes & m&a (3). It was most often mentioned alongside HK inno.N, Kolmar Korea and Cellid.

Filing signals Turnaround Screener

Bluemtec quarterly results consolidated, KRW

QuarterRevenueYoYOperating profitNet income
Q2 2026₩55.0bn+20.4%₩182m
margin 0.3%
₩2.0bn
Q1 2026₩44.0bn+28.9%−₩743m
margin −1.7%
₩2.6bn
Q4 2025 derived₩53.9bn+64.0%−₩488m
margin −0.9%
₩79m
Q3 2025₩52.1bn+10.6%₩347m
margin 0.7%
−₩487m
Q2 2025₩45.7bn+78.2%−₩800m
margin −1.8%
−₩2.5bn
Q1 2025₩34.2bn+23.7%−₩1.0bn
margin −3.0%
−₩1.6bn
Q4 2024 derived₩32.9bn-0.9%−₩3.3bn
margin −9.9%
−₩1.9bn
Q3 2024₩47.1bn+21.5%−₩234m
margin −0.5%
−₩3.4bn

Key accounts from quarterly, half-year and annual reports filed on DART. Q4 is derived as full-year minus nine-month figures. Figures may differ from preliminary earnings releases. Margin is operating profit divided by revenue — see operating margin.

Bluemtec top stories 2 weeks, by number of outlets

  1. 1
  2. 2
    블루엠텍, 경영권 매각…매각가 700억원 추정
    1 outlets · 1 articlesFirst report Sep 22 14:44 머니투데이Stake / acquisition
  3. 3
    수년 협업한 블루엠텍-콜마, 경영권 인수 검토까지 이어지나
    1 outlets · 1 articlesFirst report Sep 29 05:52 약사공론Stake / acquisition
  4. 4
    셀리드·블루엠텍, 경영권 매각 소식에 들썩…인벤테라 상승[바이오 맥짚기]
    1 outlets · 1 articlesFirst report Sep 24 08:38 이데일리Stake / acquisitionInventeraCellid

Latest Bluemtec news Korean headlines